Drug search by name

Ocrelizumab Intravenous and Breast cancer

Result of checking the interaction of drug Ocrelizumab Intravenous and disease Breast cancer for safety when used together.

Check result:

Ocrelizumab Intravenous <> Breast cancer

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Ocrelizumab may increase the risk of malignancies, including breast cancer. It is recommended to follow standard breast cancer screening guidelines. Exercise care when using this agent in patients with a history of breast cancer or other type of malignancy. Monitor closely for the development of any sign or symptom suggestive of a malignancy and treat appropriately.

Ocrelizumab Intravenous

Generic Name: ocrelizumab

Brand Name: Ocrevus

Synonyms: Ocrelizumab (Intravenous), Ocrelizumab

What is Ocrelizumab Intravenous?